SYK and ovarian cancer: In contrast, SYK has been shown to be pro-tumorigenic in prostate cancer [31], small-cell lung cancer [32], ovarian cancer [11,33], glioma [34], pediatric retinoblastoma [35], and Ewing sarcoma [36].